Otsuka Holdings
4578.T
#649
Rank
NZ$69.33 B
Marketcap
NZ$132.17
Share price
1.79%
Change (1 day)
38.96%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: NZ$1.87 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.87 Billion a decrease over its 2022 earnings that were of NZ$2.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023NZ$1.87 B-20.93%
2022NZ$2.37 B-12.7%
2021NZ$2.71 B-19.92%
2020NZ$3.39 B13.9%
2019NZ$2.98 B52.07%
2018NZ$1.95 B11.22%
2017NZ$1.76 B-36.03%
2016NZ$2.75 B31.15%
2015NZ$2.10 B
2013NZ$4.35 B33.52%
2012NZ$3.26 B-4.65%
2011NZ$3.42 B45.53%
2010NZ$2.35 B